Quince Therapeutics Q2 EPS $(0.64) Down From $(0.14) YoY
Portfolio Pulse from Benzinga Newsdesk
Quince Therapeutics reported a Q2 EPS of $(0.64), indicating a loss for the quarter.
August 13, 2024 | 8:20 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Quince Therapeutics reported a Q2 EPS of $(0.64), indicating a loss for the quarter.
The reported loss per share of $(0.64) for Q2 is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100